Cancer forms a large part of urological practice. Prostate canceris the most significant and is the second most common cause of malecancer deaths with some 300,000 cases in the USA annually. Cancerof the bladder is also common. While treatment has been primarilysurgical, recent years have seen an explosion of new drug therapiesfor urological cancers.
All urologists, whether in training or in practice, need anup-to-date survey of the literature and key findings in thisimportant and controversial field.
This book takes each organ in turn (prostate, kidney, bladder,testis and penis) and tackles the controversies head-on by invitingchapters on various (often rival) treatments for each disease. Eachsection is then concluded by a commentary from the editor whichdraws together the various strands, outlines the principal areas ofconsensus and disagreement.
Jonathan Waxman is an oncologist who specialises in urologicaltumours and has developed new treatments for prostate, bladder andkidney cancer and for terminal care, which are now part of standardpractice. He founded the Prostate Cancer Charity and helpedestablish an all-party parliamentary group to improve cancertreatment and research throughout the UK.
Jonathan Waxman
Medical Science Medizin Oncology & Radiotherapy Onkologie u. Strahlentherapie Urologie Urology